Previous studies have demonstrated that lactate levels above 4 mmol/L are unusual in normal and non-critically ill hospitalised patients, regardless of their underlying comorbidities. A lactate level above 4 mmol/l in the presence of SIRS criteria significantly increases ICU admission rates and mortality in normotensive patients. In severe sepsis and
septic shock there is a compensatory surge in catecholamines and neural regulation. This may initially preserve arterial pressure at the expense of global tissue oxygenation. Thus vital signs may be poor resuscitation endpoints, prognosticators, and indicators of the degree of tissue hypoxia. The sensitivity and specificity of a single lactate reading is debatable. However serial lactate measurements and the calculation of lactate clearance (percentage decrease from initial measurement) may be better prognosticators of organ failure and mortality.
Adequate resuscitation during the initial phase of severe sepsis is crucial. The resuscitation phase of severe sepsis forms only a small fraction of the total hospital stay, but it has huge impact on outcome. The authors examined lactate clearance during this initial phase of sepsis and prior to ICU admission. They investigated it as an indicator of outcome in patients with severe sepsis and septic shock, and hypothesised that a high lactate clearance in the first 6 hours of presentation would be associated with a decreased mortality rate.
Design
This was a prospective observational study of adults with severe sepsis or septic shock in the Emergency Department (ED) of a busy tertiary hospital over a 1 year period.
Patients were enrolled within one hour of presenting to the ED with severe sepsis or septic shock. Eligibility criteria were: 1. A suspected septic source 2. Two or more of the SIRS criteria as defined by ACCP/SCCM 1 3. Either a. SBP <90mmHg after 20ml/kg fluid challenge or b. lactate >4mmol/L Exclusion criteria were age <18yrs, AMI, pulmonary oedema, haemorrhagic shock, trauma, seizure, pregnancy, DNAR orders, or requirement for immediate surgery.
All patients had invasive arterial and central venous pressure monitoring inserted, and haemodynamic support followed a Society of Critical Care Medicine protocol. Volume resuscitation using crystalloid or colloid was initiated to achieve CVP 8-12 mmHg. Vasoactive agents were given to maintain MAP>65 mmHg. Target urine output was >0.5 ml/kg/hr. Patients were intubated and ventilated "as required".
Lactate samples were collected at presentation, and at 6 and 72 hrs. In addition to demographics, a sizeable dataset was also recorded comprising cardiovascular, haematological and biochemical results. APACHE II scores were also calculated for ED presentation, 6 and 72 hours. Lactate clearance was calculated as defined by [(lactatepresentationlactateat 6 hours) x 100 / lactatepresentation]. A positive value denotes a decrease in lactate, whereas a negative value denotes an increase in lactate.
The primary outcome was in-hospital mortality. Univariate comparisons of in-hospital mortality were made, and a value for optimal lactate clearance was identified as the clearance which had the highest combined sensitivity and specificity for predicting in-hospital mortality. Therapy and outcome measures were then compared between those patients falling into the two groups above and below this lactate clearance cut-off. 
Results

Conclusions
This study concludes that a high lactate clearance as early as possible in severe sepsis and septic shock is associated with improved mortality and morbidity. They imply that lactate clearance may have a possible role as a resuscitation endpoint.
Are the results of the study valid?
Primary and secondary guides
The investigators had no influence on clinical decision making, and although it states that the clinicians caring for the patient were blinded to the data collection process, they would have had access to the serial lactate measurements as part of the normal care of the patient. There is no mention as to whether all patients entered into the trial were accounted for at the end of the study period, or for whom how many consent was not obtained.
Of concern is that there was significant variation in the time the patient spent in the ER (range 1.5 to 17.6 hrs). The emphasis in this paper is the beneficial effect of early resuscitation. It is possible that there was a difference in care applied to those patients whether in the ER or ICU. This is not analysed in the results.
Do the results make biological and clinical sense?
Yes. It is intuitive that as a marker of improved tissue oxygenation lactate will fall, and that in those patients with the greatest proportional fall in lactate this survival advantage will be highest. This was the hypothesis of the authors and appears to have been reliably confirmed. It is however difficult to tease out a causal process. Does the reduced lactate clearance result from inadequate resuscitation, particularly in severe sepsis or is it itself driving the organ failure. Lactate can be raised in the absence of anaerobic metabolism as a result of an epinephrine driven increase in Na+ K+ ATP activity, impaired clearance due to hepatic dysfunction or pyruvate dehydrogenase dysfunction.
Are the results of this trial important? Do these results apply to our patients?
Yes. Although the results are not entirely new, they do lend credence to the serial measurement of lactate as a guide to resuscitation in sepsis and probably in shock from other aetiologies. Lactate clearance during resuscitation of septic patients has previously been shown to be predictive of mortality 2 .
The authors also performed a famous landmark study on early goal directed therapy commencing in the ED for patients with severe sepsis and septic shock 3 . The results of this trial could be taken in combination with the results of early goal directed therapy to guide initial resuscitation. ICUs in the UK tend to run at very high occupancy rates 4 and therefore there may be significant delays in ICU admission. Therefore the use of goal directed therapy and serial lactate measurements may be integral to therapy in the ED and have huge effects on outcome. The majority of UK EDs can perform point of care lactate measurements on ABG samples. The study patient group also seem to bear close resemblance to our population of sepsis patients in the UK.
What is particularly interesting is that both groups were similar at presentation in terms of temperature, MAP, HR, CVP, WBC, creatinine, pH and base deficit, reflecting the difficulty of identifying sepsis severity at early presentation. Notably 29% of the patients in the low lactate clearance group did not have hypotension at presentation. This group had a mortality of 55.6%, greater even than those patients in the high lactate clearance group presenting with septic shock (mortality 47.2%). This is testimony to the insensitivity of traditional variables such as SBP in determining resuscitation requirements; organ hypoperfusion can exist in the presence of normotension.
Lactate clearance does seem to represent a useful and clinically obtainable marker of tissue hypoxia and disease severity, which is independent of blood pressure. However although this study adds to the knowledge that early adequate resuscitation improves outcome, there are no data yet to definitively support replacing resuscitation end points used currently and invasive monitoring with lactate clearance. If lactate was used alone in the absence of invasive monitoring it would be difficult to determine the resuscitative intervention required, be it fluids, vasopressors or ionotropy. Used in conjunction with invasive haemodynamic monitoring to guide therapy, lactate clearance may have an important role in management of patients with severe sepsis and septic shock.
